Whistleblower charges drug company with deceptive practices

HFOV Charges and Reimbursement: Practices and Experience

Introduction Since its availability in the late 1960's, mechanical ventilation has led to dramatic improvements in treating infants with hyaline membrane disease (HMD). However, in today's economic environment, with each technological step taken, comes the justification of costs against the reimbursement attainable. High frequency oscillatory ventilation (HFOV) is one of those technologies whos...

Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints

BACKGROUND Despite regulatory restrictions, off-label marketing of pharmaceutical products has been common in the US. However, the scope of off-label marketing remains poorly characterized. We developed a typology for the strategies and practices that constitute off-label marketing. METHODS AND FINDINGS We obtained unsealed whistleblower complaints against pharmaceutical companies filed in US...

'I had to act': in conversation with a whistleblower.

FDA to review "missing" drug company documents.

Deceptive Advertising with Rational Buyers

We study a Bertrand game where two sellers supplying products of different and unverifiable qualities can outwit potential clients through their (costly) deceptive advertising. We characterize a class of pooling equilibria where sellers post the same price regardless of their quality and low quality ones deceive buyers. Although in these equilibria low quality goods are purchased with positive ...